Calosyn Pharma
Shreveport
About Calosyn Pharma
Calosyn Pharma focuses on developing innovative treatments for osteoarthritis. Its product, CAL-05CR, is a sustained-release injectable therapy that combines verapamil with a biodegradable delivery system. This treatment is designed to provide long-lasting pain relief and reduce inflammation by targeting the underlying causes of osteoarthritis, such as abnormal calcium ion channel signaling.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $3.3M
- Last round: Debt Financing (Dec 2022)
- Website: calosyn.com
- Phone: (318) 518-9299
Industries & Categories
Biopharma, Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/calosyn-pharma-51982 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.